Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 May 31;12(2):85-89.
doi: 10.1159/000524901. eCollection 2022 May-Aug.

Urothelial Carcinoma in an Allograft kidney

Maria Baand Hejlesen  1 , Mohammad Hassan Youssef  2 , Jesper Noergaard Bech  1 , Frank Holden Mose  1
Affiliations
Case Reports

Urothelial Carcinoma in an Allograft kidney

Maria Baand Hejlesen et al. Case Rep Nephrol Dial. .

Abstract

Patients who have been kidney transplanted have an increased risk of developing cancer. This case report presents a rarely described case in which a patient, who had received a kidney transplant from a deceased donor, was diagnosed with disseminated urothelial carcinoma originating from the allograft. After the removal of the allograft and the immunosuppressive treatment, there was regression in the cancer. Unfortunately, it was not a complete regression of the urothelial cancer and the patient died. This case indicates that there is a risk of getting cancer from the transplanted kidney from a deceased donor, but also that the immunosuppressive treatment can contribute to the development of this cancer.

Keywords: Case report; Donor; Immunosuppressive treatment; Kidney transplant; Urothelial carcinoma.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to declare.

Figures

Fig. 1
Fig. 1
PET-CT scan showing metastatic cancer. The arrow shows one of the malignant changes on the allograft kidney (the whole allograft kidney lights up and is inhomogeneously suggesting malignant changes).
See this image and copyright information in PMC

References

    1. Vajdic CM, McDonald SP, McCredie MRE, van Leeuwen MT, Stewart JH, Law M, et al. Cancer incidence before and after kidney transplantation. JAMA. 2006 Dec 20;296((23)):2823–31. - PubMed
    1. Villeneuve PJ, Schaubel DE, Fenton SS, Shepherd FA, Jiang Y, Mao Y. Cancer incidence among Canadian kidney transplant recipients. Am J Transplant. 2007 Apr 1;7((4)):941–8. - PubMed
    1. Hernández-Gaytán CA, Rodríguez-Covarrubias F, Castillejos-Molina RA, Hernández-Porras A, Tobia I, Dubin JM, et al. Urological cancers and kidney transplantation: a literature review. Curr Urol reports. 2021;22((12)):62. - PubMed
    1. Leon G, Szabla N, Boissier R, Gigante M, Caillet K, Verhoest G, et al. Kidney graft urothelial carcinoma: results from a multicentric retrospective national study. Urology. 2020 Jan 1;135:101–5. - PubMed
    1. Debout A, Foucher Y, Trébern-Launay K, Legendre C, Kreis H, Mourad G, et al. Each additional hour of cold ischemia time significantly increases the risk of graft failure and mortality following renal transplantation. Kidney Int. 2015 Feb 3;87((2)):343–9. - PubMed

Publication types